Palatin Technologies Inc (PTN) - Financial and Strategic SWOT Analysis Review

October 2021 | 53 pages | ID: PA32F58B306EN
GlobalData

Abstracts

Palatin Technologies Inc (PTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Palatin Technologies Inc (Palatin) is a biopharmaceutical company that develops receptor-specific peptide therapeutics. The company’s medicines are based on molecules that control the activity of the melanocortin and natriuretic peptide receptor systems. Its lead product includes Vyleesi, indicated for the treatment of premenopausal women with hypoactive sexual desire disorder. Palatin clinical pipeline includes melanocortin receptor programs such as PL-8177 MC1r Agonist (oral) for inflammatory bowel disease; PL9643 MCr Agonist for dry eye diseases; PL-8177 MC1r Agonist (systemic) for Covid-19 infection; and MC4r Agonist for diabetic retinopathy. Its natriuretic peptide receptor programs include PL-3994 NPR-A for heart failure and PL-5028 NPR-A/C Agonist for heart failure and fibrosis. Palatin is headquartered in Cranbury, New Jersey, the US.

Palatin Technologies Inc Key Recent Developments

Sep 29,2021: Palatin Reports Fourth Quarter and Full Year Fiscal Year 2021 Financial Results and Provides Corporate Update
Sep 27,2021: Palatin announces presentation of positive protective effects of PL8331 and PL9654 on retinal inflammation at the 2021 American Society of Retina Specialists (ASRS) Annual Meeting
Sep 24,2021: Palatin To Report Fourth Quarter And Fiscal Year End 2021 Results; Teleconference And Webcast To Be Held On September 29, 2021
Sep 13,2021: Palatin to Participate in H.C. Wainwright 23rd Annual Global Investment Virtual Conference
Jun 28,2021: Palatin Announces New Additions to Its Senior Leadership Team

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Palatin Technologies Inc - Key Facts
Palatin Technologies Inc - Key Employees
Palatin Technologies Inc - Key Employee Biographies
Palatin Technologies Inc - Major Products and Services
Palatin Technologies Inc - History
Palatin Technologies Inc - Company Statement
Palatin Technologies Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Palatin Technologies Inc - Business Description
R&D Overview
Palatin Technologies Inc - Corporate Strategy
Palatin Technologies Inc - SWOT Analysis
SWOT Analysis - Overview
Palatin Technologies Inc - Strengths
Palatin Technologies Inc - Weaknesses
Palatin Technologies Inc - Opportunities
Palatin Technologies Inc - Threats
Palatin Technologies Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Palatin Technologies Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 29, 2021: Palatin Reports Fourth Quarter and Full Year Fiscal Year 2021 Financial Results and Provides Corporate Update
Sep 27, 2021: Palatin announces presentation of positive protective effects of PL8331 and PL9654 on retinal inflammation at the 2021 American Society of Retina Specialists (ASRS) Annual Meeting
Sep 24, 2021: Palatin To Report Fourth Quarter And Fiscal Year End 2021 Results; Teleconference And Webcast To Be Held On September 29, 2021
Sep 13, 2021: Palatin to Participate in H.C. Wainwright 23rd Annual Global Investment Virtual Conference
Jun 28, 2021: Palatin Announces New Additions to Its Senior Leadership Team
Jun 10, 2021: Palatin Announces Adjournment of Annual Meeting of Stockholders
May 17, 2021: Palatin Reports Financial Results for the Third Fiscal Quarter of 2021 and Provides Corporate Update
Mar 05, 2021: Palatin Technologies to Participate in H.C. Wainwright Global Life Sciences Virtual Conference
Feb 17, 2021: Palatin Technologies reports second quarter fiscal year 2021 financial results and recent business highlights
Feb 12, 2021: Palatin Technologies, Inc. to Report Second Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on February 17, 2021

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Palatin Technologies Inc, Key Facts
Palatin Technologies Inc, Key Employees
Palatin Technologies Inc, Key Employee Biographies
Palatin Technologies Inc, Major Products and Services
Palatin Technologies Inc, History
Palatin Technologies Inc, Subsidiaries
Palatin Technologies Inc, Key Competitors
Palatin Technologies Inc, Ratios based on current share price
Palatin Technologies Inc, Annual Ratios
Palatin Technologies Inc, Annual Ratios (Cont...1)
Palatin Technologies Inc, Annual Ratios (Cont...2)
Palatin Technologies Inc, Interim Ratios
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Palatin Technologies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Palatin Technologies Inc, Performance Chart (2017 - 2021)
Palatin Technologies Inc, Ratio Charts
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021